➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Boehringer Ingelheim
AstraZeneca
Harvard Business School
Colorcon

Last Updated: October 21, 2021

DrugPatentWatch Database Preview

Levocarnitine - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic sources for levocarnitine and what is the scope of freedom to operate?

Levocarnitine is the generic ingredient in four branded drugs marketed by Leadiant Biosci Inc, Am Regent, Teva Pharms Usa, West-ward Pharms Int, Akorn, Lyne, Novitium Pharma, and Rising, and is included in ten NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Levocarnitine has four patent family members in four countries.

There are four drug master file entries for levocarnitine. Five suppliers are listed for this compound.

Summary for levocarnitine
Drug Prices for levocarnitine

See drug prices for levocarnitine

Recent Clinical Trials for levocarnitine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mabaret Al-Asafara HospitalsPhase 4
Vanderbilt University Medical CenterPhase 2
University of GuadalajaraPhase 2

See all levocarnitine clinical trials

Pharmacology for levocarnitine

US Patents and Regulatory Information for levocarnitine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Leadiant Biosci Inc CARNITOR levocarnitine INJECTABLE;INJECTION 020182-001 Dec 16, 1992 AP RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Leadiant Biosci Inc CARNITOR levocarnitine INJECTABLE;INJECTION 020182-001 Dec 16, 1992 AP RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
West-ward Pharms Int LEVOCARNITINE levocarnitine INJECTABLE;INJECTION 075567-001 Mar 29, 2001 AP RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for levocarnitine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Leadiant Biosci Inc CARNITOR levocarnitine INJECTABLE;INJECTION 020182-001 Dec 16, 1992 ⤷  Try it Free ⤷  Try it Free
Leadiant Biosci Inc CARNITOR levocarnitine INJECTABLE;INJECTION 020182-001 Dec 16, 1992 ⤷  Try it Free ⤷  Try it Free
Leadiant Biosci Inc CARNITOR levocarnitine INJECTABLE;INJECTION 020182-001 Dec 16, 1992 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Boehringer Ingelheim
AstraZeneca
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.